Doctor holding the hand of a patient

About Us

About Us

AngioBrain Therapeutics is developing first-in-class therapies designed to promote therapeutic angiogenesis in the adult brain, with
the potential to enhance brain tissue repair and recovery. By targeting vascular dysfunction as a fundamental driver of neurological
disease, AngioBrain aims to establish a new therapeutic paradigm for stroke and other neurological disorders.

Our Vision

To become the leader in neurovascular
regenerative medicine.

Leadership

Driven by Science. Focused on Impact.

Portrait of Dr. Peeyush Kumar Thankamani Pandit

Peeyush Kumar
Thankamani Pandit, PhD

Founder

Dr. Peeyush Pandit is a neuroscientist and vascular biology
researcher with extensive expertise in CNS vascular biology
and translational neuroscience. He earned his PhD from
Cochin University of Science and Technology, India, and
subsequently pursued advanced research fellowships at
Harvard Medical School and the University of Wisconsin,
where he developed expertise in the biology of the
neurovascular system. He later established an independent
research laboratory at the University of Texas Health Science
Center at Houston, advancing research at the intersection of
vascular biology and neurological disease. At AngioBrain, Dr.
Pandit brings deep scientific expertise and research
leadership to the development of innovative approaches
targeting neurovascular mechanisms underlying neurological
disorders.

Portrait of Dr. Reas Khan Sulaimankutty

Reas Khan
Sulaimankutty, PhD

Founder and CEO

Dr. Reas Khan is a molecular neuroscientist and
biotechnology leader with expertise spanning neuroscience,
ophthalmology, gene therapy, and therapeutic development.
He earned his PhD in Molecular Neuroscience from Cochin
University of Science and Technology and advanced his
research career through postdoctoral and senior research
roles at the University of Pennsylvania. He subsequently
served as a Senior Scientist at PTC Therapeutics,
contributing to the development of innovative therapeutic
programs. As Founder and CEO of AngioBrain, Dr. Khan
provides scientific and strategic leadership, driving the
company’s efforts to translate advances in neurovascular
biology into transformative therapies for neurological and
vascular diseases.

Portrait of Dr. Spiros Blackburn

Spiros
Blackburn, MD

Co-Founder and Medical Director

Dr. Spiros Blackburn is a board-certified neurosurgeon and
clinical leader with extensive expertise in cerebrovascular
and neurovascular disease, including skull base, endoscopic,
and endovascular neurosurgery. His multidisciplinary training
at leading academic medical centers, including UT
Southwestern Medical School, Washington University in St.
Louis, Emory University, and the Mallinckrodt Institute of
Radiology, has shaped a broad perspective spanning
complex neurosurgical care and advanced neurovascular
therapies. At AngioBrain, Dr. Blackburn brings valuable clinical
insight and expertise in cerebrovascular disease to support
the translation of innovative neurovascular science into
clinically meaningful therapeutic approaches.

Values

Our Values

Scientific Excellence

Patient Impact

Innovation

Integrity

Collaboration

Company Statement

Building a New Paradigm in
Brain Repair

AngioBrain Therapeutics is developing first-in-class therapies designed to target the brain endothelium
and promote therapeutic angiogenesis in diseased brains where the cerebral vasculature is compromised.
By restoring the brain’s vascular environment, we aim to unlock new opportunities for brain repair
and improve long-term outcomes and quality of life for patients living with neurological disorders.